Five Prime Therapeutics Appoints Aron Knickerbocker to Its Board of Directors and Marc Belsky to Chief Financial Officer

Five Prime Therapeutics, Inc. (Nasdaq: FPRX ) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced the appointment of Aron Knickerbocker, Senior Vice President and Chief Business Officer of Five Prime, to the company's Board of Directors